FamiCord AG (ETR:V3V)

Germany flag Germany · Delayed Price · Currency is EUR
5.00
-0.05 (-0.99%)
At close: Mar 6, 2026
Market Cap87.16M +20.2%
Revenue (ttm)88.29M +9.5%
Net Income-9.80M
EPS-0.58
Shares Out17.43M
PE Ration/a
Forward PE62.50
Dividendn/a
Ex-Dividend Daten/a
Volume1,161
Average Volume1,766
Open4.96
Previous Close5.05
Day's Range4.90 - 5.10
52-Week Range3.70 - 7.65
Beta0.70
RSI31.31
Earnings DateApr 30, 2026

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa... [Read more]

Sector Healthcare
Founded 1997
Employees 766
Stock Exchange Deutsche Börse Xetra
Ticker Symbol V3V
Full Company Profile

Financial Performance

In 2024, FamiCord AG's revenue was 82.18 million, an increase of 6.65% compared to the previous year's 77.06 million. Losses were -12.14 million, 550.7% more than in 2023.

Financial Statements